TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 122 filers reported holding TCR2 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $61,000 | -52.0% | 22,200 | -18.7% | 0.00% | – |
Q4 2021 | $127,000 | -45.3% | 27,300 | 0.0% | 0.00% | – |
Q3 2021 | $232,000 | -48.2% | 27,300 | 0.0% | 0.00% | – |
Q2 2021 | $448,000 | -2.0% | 27,300 | +31.9% | 0.00% | – |
Q1 2021 | $457,000 | -38.7% | 20,700 | -14.1% | 0.00% | – |
Q4 2020 | $745,000 | +232.6% | 24,100 | +119.1% | 0.00% | – |
Q3 2020 | $224,000 | -9.3% | 11,000 | -31.7% | 0.00% | – |
Q2 2020 | $247,000 | – | 16,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,050,865 | $34,473,000 | 7.99% |
MPM BioImpact LLC | 3,370,982 | $28,687,000 | 4.45% |
Ghost Tree Capital, LLC | 477,323 | $4,062,000 | 1.19% |
Redmile Group, LLC | 3,816,709 | $32,480,000 | 0.57% |
First Light Asset Management, LLC | 620,887 | $5,284,000 | 0.35% |
AlphaCentric Advisors LLC | 113,000 | $962,000 | 0.24% |
Cormorant Asset Management, LP | 479,506 | $4,081,000 | 0.17% |
Artal Group S.A. | 750,000 | $6,383,000 | 0.14% |
X-Square Capital, LLC | 32,003 | $272,000 | 0.14% |
Altium Capital Management LP | 59,150 | $503,000 | 0.13% |